NextCure, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2018 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
NextCure, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2018 to Q3 2024.
  • NextCure, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$11.5M, a 19.3% increase year-over-year.
  • NextCure, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$58.5M, a 10.7% increase year-over-year.
  • NextCure, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$62.7M, a 16.1% increase from 2022.
  • NextCure, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$74.7M, a 7.7% decline from 2021.
  • NextCure, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$69.4M, a 89.6% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$58.5M -$11.5M +$2.76M +19.3% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 -$61.3M -$15.4M +$2.46M +13.7% Apr 1, 2024 Jun 30, 2024 10-Q 2024-11-07
Q1 2024 -$63.7M -$17.1M -$1.01M -6.28% Jan 1, 2024 Mar 31, 2024 10-Q 2024-11-07
Q4 2023 -$62.7M -$14.5M +$2.83M +16.4% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-21
Q3 2023 -$65.6M -$14.3M +$4.61M +24.4% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 -$70.2M -$17.9M +$61K +0.34% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-07
Q1 2023 -$70.2M -$16.1M +$4.51M +21.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-07
Q4 2022 -$74.7M -$17.3M -$361K -2.13% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-21
Q3 2022 -$74.4M -$18.9M -$981K -5.47% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 -$73.4M -$17.9M +$67K +0.37% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-02
Q1 2022 -$73.5M -$20.6M -$4.07M -24.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-02
Q4 2021 -$69.4M -$16.9M -$1.48M -9.56% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-02
Q3 2021 -$67.9M -$17.9M -$1.56M -9.55% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 -$66.3M -$18M -$3.48M -24% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-03
Q1 2021 -$62.9M -$16.5M -$26.3M -270% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-03
Q4 2020 -$36.6M -$15.5M -$4.53M -41.5% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-03
Q3 2020 -$32.1M -$16.4M -$7.93M -94.1% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 -$24.1M -$14.5M -$6.29M -76.5% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-04
Q1 2020 -$17.8M $9.73M +$15.9M Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-04
Q4 2019 -$33.7M -$10.9M -$4.07M -59.2% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-04
Q3 2019 -$29.7M -$8.43M -$2.72M -47.7% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 -$26.9M -$8.22M -$2.99M -57.2% Apr 1, 2019 Jun 30, 2019 10-Q 2020-11-05
Q1 2019 -$24M -$6.16M -$1.16M -23.2% Jan 1, 2019 Mar 31, 2019 10-Q 2020-11-05
Q4 2018 -$22.8M -$6.86M Oct 1, 2018 Dec 31, 2018 10-K 2020-03-12
Q3 2018 -$5.71M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 -$5.23M Apr 1, 2018 Jun 30, 2018 10-Q 2019-11-12
Q1 2018 -$5M Jan 1, 2018 Mar 31, 2018 10-Q 2019-11-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.